Bio-Techne Corp (TECH) Social Stream



Bio-Techne Corp (TECH): $284.00

-1.63 (-0.57%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TECH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

BIO-TECHNE CORP (TECH) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BIO-TECHNE CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 9 $600 $400 $510.625 $285.63 78.77%
2021-12-01 9 $600 $400 $511.875 $285.63 79.21%
2022-02-01 9 $600 $400 $506.25 $285.63 77.24%
2022-03-01 6 $600 $540 $565 $285.63 97.81%
2022-04-25 7 $600 $370 $532.5 $285.63 86.43%
2022-05-05 7 $575 $370 $515.833 $285.63 80.59%
2022-06-06 7 $575 $370 $506.428 $285.63 77.3%
2022-08-04 6 $580 $370 $507.142 $285.63 77.55%
2022-08-05 6 $580 $370 $491.428 $285.63 72.05%
2022-09-22 6 $580 $360 $490 $285.63 71.55%

The Trend in the Analyst Price Target


TECH's average price target has moved up $151.44 over the prior 20 months.

Over the past 46 weeks, TECH's average upside potential has been 33.73%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-01 9 600 400 511.875 461.94 10.81%
2022-01-07 9 600 400 506.250 415.28 21.91%
2022-02-01 9 600 410 542.500 401.57 35.09%
2022-02-01 7 600 400 506.250 401.57 26.07%
2022-03-01 7 600 540 565.000 420.18 34.47%

TECH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 5 0 0 1 1 6

The Trend in the Broker Recommendations


TECH's average broker recommendation rating worsened by 0.1 over the prior 123 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TECH as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, BIO-TECHNE CORP's average analyst price target is higher than 1571.72% of them.
  • In terms of how BIO-TECHNE CORP fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 262.61% of that group.
  • BIO-TECHNE CORP's variance in analysts' estimates is lower than -291.4% of Pharmaceutical Products stocks.
  • TECH has a higher upside potential (average analyst target price relative to current price) than 1155.47% of stocks in the large market cap category.

In the Pharmaceutical Products industry, SGEN, RGEN, and QGEN are the three stocks most similar to BIO-TECHNE CORP regarding the price target and analyst recommendation information presented here.

Is TECH a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6045 seconds.